These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29040561)

  • 1. Prospective evaluation of a continuous infusion vancomycin dosing nomogram in critically ill patients undergoing continuous venovenous haemofiltration.
    Sin JH; Newman K; Elshaboury RH; Yeh DD; de Moya MA; Lin H
    J Antimicrob Chemother; 2018 Jan; 73(1):199-203. PubMed ID: 29040561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Chaijamorn W; Jitsurong A; Wiwattanawongsa K; Wanakamanee U; Dandecha P
    Int J Antimicrob Agents; 2011 Aug; 38(2):152-6. PubMed ID: 21636256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion versus intermittent infusion of vancomycin in critically ill patients undergoing continuous venovenous hemofiltration: a prospective interventional study.
    Xu J; Duan L; Li J; Chen F; Xu X; Lu J; Zhuang Z; Cao Y; Yuan Y; Liu X; Sun J; Zhou Q; Shi L; Tang L
    BMC Infect Dis; 2022 Aug; 22(1):667. PubMed ID: 35918657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of and maintenance dose recommendations for vancomycin in severe pneumonia patients undergoing continuous venovenous hemofiltration with the combination of predilution and postdilution.
    Li Q; Liang F; Sang L; Li P; Lv B; Tan L; Liu X; Chen W
    Eur J Clin Pharmacol; 2020 Feb; 76(2):211-217. PubMed ID: 31734748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients.
    Roger C; Cotta MO; Muller L; Wallis SC; Lipman J; Lefrant JY; Roberts JA
    Int J Antimicrob Agents; 2017 Aug; 50(2):227-231. PubMed ID: 28689876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of continuous venovenous hemofiltration dose on achievement of adequate vancomycin trough concentrations.
    Frazee EN; Kuper PJ; Schramm GE; Larson SL; Kashani KB; Osmon DR; Leung N
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6181-5. PubMed ID: 22985887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
    Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
    Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Extracorporeal Membrane Oxygenation on the New Vancomycin Dosing Regimen in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration.
    Yang CJ; Wu CW; Wu CC
    Ther Drug Monit; 2018 Jun; 40(3):310-314. PubMed ID: 29746432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration.
    Jamal JA; Roberts DM; Udy AA; Mat-Nor MB; Mohamad-Nor FS; Wallis SC; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2015 Jul; 46(1):39-44. PubMed ID: 25881872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration.
    Jamal JA; Mat-Nor MB; Mohamad-Nor FS; Udy AA; Wallis SC; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2015 Jan; 45(1):41-5. PubMed ID: 25455853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin clearance in high-volume venovenous hemofiltration.
    Paciullo CA; Harned KC; Davis GA; Connor MJ; Winstead PS
    Ann Pharmacother; 2013 Mar; 47(3):e14. PubMed ID: 23404801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of dosing strategies and trough concentrations of vancomycin in patients undergoing continuous venovenous hemofiltration.
    Wahby KA; Cunmuljaj L; Mouabbi K; Almadrahi Z; Wilpula L
    Pharmacotherapy; 2021 Jul; 41(7):554-561. PubMed ID: 33963536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy.
    Akers KS; Cota JM; Chung KK; Renz EM; Mende K; Murray CK
    J Burn Care Res; 2012; 33(6):e254-62. PubMed ID: 22878490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram.
    Baptista JP; Roberts JA; Sousa E; Freitas R; Deveza N; Pimentel J
    Crit Care; 2014 Dec; 18(6):654. PubMed ID: 25475123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of polymyxin B in critically ill patients receiving continuous venovenous haemofiltration.
    Wang P; Xing H; Zhang F; Liu S; Lu Y; Zhang X; Yang J; Sun T
    Int J Antimicrob Agents; 2022 Jul; 60(1):106599. PubMed ID: 35526750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin continuous infusion versus intermittent infusion during continuous venovenous hemofiltration: slow and steady may win the race.
    Lin H; Bukovskaya Y; De Moya M; Lee J; Schmidt U
    Ann Intensive Care; 2015; 5():10. PubMed ID: 25995967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
    Petejova N; Martinek A; Zahalkova J; Duricova J; Brozmannova H; Urbanek K; Grundmann M; Plasek J; Kacirova I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):65-72. PubMed ID: 23132513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of vancomycin in continuous veno-venous hemofiltration].
    Gu Q; Zhu ZH; Ge M; Ge WH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Feb; 15(2):114-6. PubMed ID: 12857476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
    Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
    Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.